AbbVie Foundation is supporting MAP International’s program to increase access to early diagnosis through awareness raising and active early case detection and building the capacity of community healthcare workers and health professionals through training in early case detection, prevention of disabilities and continuum of treatment.
The AbbVie Foundation partnership is designed to focus on clearly defined populations, leveraging MAP’s past progress in Buruli ulcer, and relying on community health workers and established local partners.
Increasing the numbers of health professionals and others, including community health workers trained in BU control enables an increase in the number of cases detected and treated in the early stages: More than 70% of BU cases detected in 2011 and 2012 are early stages compared to 20% in 2008.
Since 2010, AbbVie Foundation (initially as Abbott Fund) has invested $580,000 in cash grants. In 2014 the partnership will expand to target three endemic districts and integrate mobile technology to improve surveillance, monitoring and evaluation, and patient care.
Summary of impact through December 2013 :
|Location||West Africa, Cote d Ivoire|